Whilst Prothena has said that it is still examining the late-stage treatment, the company confirmed it failed to meet its ...

Teachers lack the capacity to employ effective learning methods, particularly at the pre-primary and secondary education level, as only three percent of teachers received specialised training in ...

Vertex Pharmaceuticals (VRTX) announced results from its Phase 2 study of suzetrigine, an investigational, oral, highly selective NaV1.8 pain ...

PADOVA study showed numerical delay in motor progression and positive trends on multiple secondary and exploratory endpoints; ...